Advertisement Scynexis licenses HEOS drug discovery software platform to TB Alliance - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Scynexis licenses HEOS drug discovery software platform to TB Alliance

Scynexis, a provider of drug discovery and development solutions, has licensed its HEOS SaaS software platform for drug discovery to TB Alliance to accelerate tuberculosis (TB) research activities.

HEOS is a drug research information management software platform that provides a secure, user-friendly data handling system and allows collaborators to view results and make informed decisions.

Powered by Accelrys tools including Accord data cartridge and Pipeline Pilot, HEOS supports geographically distributed scientists and facilitates collaboration.

Scynexis president and CEO Yves Ribeill said HEOS has become the standard collaborative research software platform in the Global Health area.